- Home
- KRMD vs FT Comparison
KRMD vs FT Comparison
Compare KRMD & FT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRMD
- FT
- Stock Information
- Founded
- KRMD 1980
- FT 1988
- Country
- KRMD United States
- FT United States
- Employees
- KRMD N/A
- FT N/A
- Industry
- KRMD Medical/Dental Instruments
- FT Trusts Except Educational Religious and Charitable
- Sector
- KRMD Health Care
- FT Finance
- Exchange
- KRMD Nasdaq
- FT Nasdaq
- Market Cap
- KRMD 187.5M
- FT 185.7M
- IPO Year
- KRMD N/A
- FT N/A
- Fundamental
- Price
- KRMD $4.10
- FT $7.55
- Analyst Decision
- KRMD Strong Buy
- FT
- Analyst Count
- KRMD 5
- FT 0
- Target Price
- KRMD $4.50
- FT N/A
- AVG Volume (30 Days)
- KRMD 118.1K
- FT 63.0K
- Earning Date
- KRMD 03-12-2025
- FT 01-01-0001
- Dividend Yield
- KRMD N/A
- FT 7.85%
- EPS Growth
- KRMD N/A
- FT N/A
- EPS
- KRMD N/A
- FT N/A
- Revenue
- KRMD $31,993,796.00
- FT N/A
- Revenue This Year
- KRMD $20.04
- FT N/A
- Revenue Next Year
- KRMD $14.15
- FT N/A
- P/E Ratio
- KRMD N/A
- FT N/A
- Revenue Growth
- KRMD 11.57
- FT N/A
- 52 Week Low
- KRMD $1.98
- FT $5.97
- 52 Week High
- KRMD $4.60
- FT $7.23
- Technical
- Relative Strength Index (RSI)
- KRMD 57.62
- FT 60.09
- Support Level
- KRMD $3.81
- FT $7.19
- Resistance Level
- KRMD $4.30
- FT $7.65
- Average True Range (ATR)
- KRMD 0.19
- FT 0.09
- MACD
- KRMD -0.00
- FT 0.04
- Stochastic Oscillator
- KRMD 60.90
- FT 78.26
About KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets, and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
About FT Franklin Universal Trust
Franklin Universal Trust is a closed-end management investment company. Its primary investment objective is to provide high, current income consistent with the preservation of capital. Its secondary objective is the growth of income through dividend increases and capital appreciation. The fund invests in two asset classes being the high yield bonds and utility stocks.